MedPath

Ketoprofen

Generic Name
Ketoprofen
Drug Type
Small Molecule
Chemical Formula
C16H14O3
CAS Number
22071-15-4
Unique Ingredient Identifier
90Y4QC304K

Overview

Ketoprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with analgesic and antipyretic properties.

Background

Ketoprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with analgesic and antipyretic properties.

Indication

For symptomatic treatment of acute and chronic rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, primary dysmenorrhea and mild to moderate pain associated with musculotendinous trauma (sprains and strains), postoperative (including dental surgery) or postpartum pain.

Associated Conditions

  • Ankylosing Spondylitis (AS)
  • Migraine
  • Mild pain
  • Osteoarthritis (OA)
  • Post Partum Pain
  • Postoperative pain
  • Primary Dysmenorrhoea
  • Rheumatoid Arthritis
  • Moderate Pain

FDA Approved Products

Ketoprofen
Manufacturer:Misemer Pharmaceuticals, Inc.
Route:ORAL
Strength:25 mg in 1 1
Approved: 2024/02/01
NDC:0276-0504
Ketoprofen
Manufacturer:Misemer Pharmaceuticals, Inc.
Route:ORAL
Strength:50 mg in 1 1
Approved: 2024/02/01
NDC:0276-0506

Singapore Approved Products

FASTUM GEL 2.5%
Manufacturer:A. MENARINI MANUFACTURING LOGISTICS AND SERVICES S.R.L.
Form:GEL
Strength:2.5 g/100 g
Online:Yes
Approved: 1992/01/04
Approval:SIN06755P
PRONALGES 50 TABLET 50 mg
Manufacturer:PT DEXA MEDICA
Form:ENTERIC COATED TABLET
Strength:50 mg
Online:Yes
Approved: 2002/10/31
Approval:SIN12115P
PRONALGES 100 TABLET 100 mg
Manufacturer:PT DEXA MEDICA
Form:ENTERIC COATED TABLET
Strength:100 mg
Online:Yes
Approved: 2002/12/23
Approval:SIN12153P
HARUFEN PLASTER 30MG
Manufacturer:SINIL Pharmaceutical Co., Ltd.
Form:PLASTER
Strength:30 mg
Online:Yes
Approved: 2022/03/21
Approval:SIN16447P
KEFENTECH PLASTER 30 mg/sheet
Manufacturer:JEIL HEALTH SCIENCE
Form:PLASTER
Strength:30 mg/sheet
Online:Yes
Approved: 1999/02/25
Approval:SIN10768P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath